Home » Topics » BioWorld Science

BioWorld Science
RSS

INO-4700 MERS-CoV vaccine candidate enters phase II studies

June 4, 2021

PINK1 and Parkin stabilize mutations in mitochondrial DNA

June 4, 2021

Novartis initiates recruitment in phase I study of INE-963

June 4, 2021

Evaxion reports preclinical proof-of-concept data for its AI-powered RAVEN vaccine platform

June 4, 2021

BI-655064 does not meet CRR primary endpoint in lupus nephritis phase II trial

June 4, 2021

University of California identifies ROR2-targeting antibodies for cancer

June 4, 2021

Hangzhou Hertz Pharmaceutical divulges PD-1/PD-L1 interaction inhibitors

June 4, 2021

Dermira synthesizes new MRGPRX2 antagonists

June 4, 2021

LG Chem discloses new melanocortin MC4 receptor agonists

June 4, 2021

Betta Pharmaceuticals patents PI3K inhibitors

June 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...